Centessa Pharmaceuticals plc
CNTA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $383 | $128 | $394 | $595 |
| Short-Term Investments | $99 | $129 | $0 | $0 |
| Receivables | $45 | $39 | $27 | $17 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $9 | $19 | $17 | $17 |
| Total Curr. Assets | $536 | $315 | $438 | $629 |
| Property Plant & Equip (Net) | $12 | $13 | $1 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $27 | $30 | $4 | $0 |
| Other NC Assets | $2 | $3 | $2 | $1 |
| Total NC Assets | $40 | $45 | $7 | $1 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $577 | $360 | $444 | $630 |
| Liabilities | – | – | – | – |
| Payables | $7 | $12 | $14 | $8 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $1 | $0 | $2 | $1 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $50 | $27 | $23 | $16 |
| Total Curr. Liab. | $58 | $39 | $38 | $25 |
| LT Debt | $117 | $85 | $70 | $76 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $38 |
| Total NC Liab. | $117 | $85 | $70 | $113 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $8 | $9 | $0 | $0 |
| Total Liabilities | $175 | $124 | $108 | $138 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$989 | -$753 | -$602 | -$386 |
| AOCI | $4 | $1 | -$1 | $1 |
| Other Equity | $1,386 | $987 | $939 | $876 |
| Total Equity | $402 | $236 | $336 | $492 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $577 | $360 | $444 | $630 |
| Net Debt | -$266 | -$43 | -$324 | -$519 |